What is the difference between Amjevita and Humira?
Medically reviewed by Drugs.com. Last updated on Sep 16, 2019.
Amjevita (adalimumab-atto) is the first adalimumab (Humira) biosimilar approved by the FDA and, like Humira, is used in adults for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis; it is also approved for juvenile idiopathic arthritis (JIA) in children 4 years and older.
Amjevita is not approved to treat hidradenitis suppurativa, or uveitis, like Humira.
Amjevita is not approved as an interchangeable product at the pharmacy, meaning the pharmacist needs approval from the prescribing doctor to substitute Amjevita for Humira, if not specified on the prescription.
Like Humira, Amjevita is an anti-TNF-α monoclonal antibody that has the same amino acid sequence as adalimumab.
Common side effects include infections and injection site reactions. Amjevita is available in a prefilled syringe or autoinjector and is given by a subcutaneous injection.
For more information, see Comparing Amjevita vs Humira
Related Medical Questions
- Does Humira cause weight gain or weight loss?
- How long does it take for Humira to work?
- What happens when you stop taking Humira?
- How much does Humira cost without insurance?
- Can you drink alcohol while taking Humira?
- How long can Humira be out of the fridge?
- How long can you stay on Humira?
Related Support Groups
- Humira (89 questions, 336 members)
- Rheumatoid Arthritis (385 questions, 1213 members)
- Ulcerative Colitis (36 questions, 170 members)
- Psoriatic Arthritis (47 questions, 236 members)
- Plaque Psoriasis (22 questions, 62 members)
- Crohn's Disease (43 questions, 265 members)
- Ankylosing Spondylitis (26 questions, 191 members)
- Juvenile Idiopathic Arthritis